[144] USANA Health Sciences Inc SEC Filing

Rhea-AI Filing Summary

USANA Health Sciences (USNA) filed a Form 144 indicating an insider’s intent to sell 3,515 common shares through Morgan Stanley Smith Barney on or after 30 Jul 2025. The shares have an aggregate market value of $106,364, based on the filing date, and represent roughly 0.02 % of the company’s 18.6 million shares outstanding.

The stock being sold was acquired as restricted-stock awards: 1,138 shares granted on 4 Feb 2022 and 2,377 shares granted on 6 Feb 2025. No prior insider sales were reported in the past three months, and the filer affirms possession of no undisclosed material adverse information.

The transaction is modest relative to USNA’s float and appears to be a routine liquidity event rather than a signal of fundamental change. Nevertheless, investors often monitor Form 144 filings for potential sentiment shifts among insiders.

Insights

Securities Analyst

TL;DR: Small insider sale (~0.02% float) is routine; negligible fundamental impact.

At just over $106k, the proposed disposition of 3,515 shares looks de-minimis for a $1.3 bn-market-cap company. The shares stem from standard equity compensation grants and are moving through a major broker, suggesting an orderly sale. Insider activity can hint at sentiment, but the absence of additional recent sales or adverse disclosures limits interpretive value. I rate the filing neutral to share-price fundamentals.

Corporate Governance Expert

TL;DR: Filing signals compliance; volume too small to raise governance red flags.

The filer followed Rule 144 disclosure, indicating awareness of reporting obligations. No aggregation of related-party sales is required, and the representation affirms no undisclosed material info, mitigating litigation risk. Volume sold is immaterial, so governance concerns are minimal. Overall, this is standard housekeeping rather than a directional cue.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3515	106363.90	18623075	07/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/04/2022	Restricted Stock	Issuer			1138	02/04/2022	Not Applicable
Common	02/06/2025	Restricted Stock	Issuer			2377	02/06/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)